EXOZ Exozymes Inc.

Fundamentals / CIK 0002010788 / USD

Exozymes Inc. reported $5.86M in total assets and a net loss of $10.14M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EXOZ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$1.04M$518K$0-$8.57MFY 2023 Revenue: $70KFY 2023 Net Income: -$2.04M2023FY 2024 Net Income: -$5.86M2024FY 2025 Net Income: -$9.16M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue -- -- $70K
Research & Development $3.71M $1.87M $527K
Operating Income -$9.72M -$5.93M -$1.80M
EBITDA -$9.48M -$5.72M -$1.65M
Income Before Tax -$9.26M -$5.86M -$2.00M
Income Tax Expense -$105K -- $42K
Net Income -$9.16M -$5.86M -$2.04M
Basic EPS -$1.09 -$0.89 -$0.33
Diluted EPS -$1.09 -$0.89 -$0.33
Basic Shares Outstanding 8.4M 6.6M 6.3M
Diluted Shares Outstanding 8.4M 6.6M 6.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.62M $1.44M $1.12M $1.11M $1.22M $803K $575K $630K
Operating Income -$3.05M -$2.95M -$2.39M -$2.70M -$2.52M -$2.55M -$1.95M -$1.98M
EBITDA -$2.98M -$2.89M -$2.32M -$2.63M -$2.46M -$2.49M -$1.89M -$1.93M
Income Before Tax -$2.24M -$2.88M -$2.37M -$2.76M -$2.29M -$2.36M -$1.86M -$1.84M
Net Income -$2.24M -$2.88M -$2.37M -$2.66M -$2.29M -$2.36M -$1.86M -$1.84M
Basic EPS -$0.24 -$0.33 -$0.28 -- -$0.27 -$0.28 -$0.22 --
Diluted EPS -$0.24 -$0.33 -$0.28 -- -$0.27 -$0.28 -$0.22 --
Basic Shares Outstanding 9.3M 8.7M 8.5M -- 8.4M 8.4M 8.4M --
Diluted Shares Outstanding 9.3M 8.7M 8.5M -- 8.4M 8.4M 8.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.04M $9.72M $67K
Cash & Short-Term Investments $3.04M $9.72M $67K
Total Current Assets $3.94M $10.82M $1.21M
Property, Plant & Equipment, Net $764K $882K $753K
Total Non-Current Assets $2.03M $2.21M $2.34M
Total Assets $5.97M $13.03M $3.56M
Accounts Payable $1.24M $924K $703K
Other Current Liabilities $5.3K $179K $445K
Total Current Liabilities $1.57M $1.33M $2.42M
Total Non-Current Liabilities $1.01M $1.28M $1.53M
Total Liabilities $2.57M $2.61M $3.94M
Total Debt (incl. Leases) $1.24M $1.39M $1.61M
Common Stock $8 $8 $6
Retained Earnings -$21.10M -$11.95M -$6.08M
Total Stockholders' Equity $3.40M $10.42M -$384K
Total Equity $3.40M $10.42M -$384K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.26M $5.65M $1.44M $3.04M $5.10M $6.99M $8.51M $9.72M
Cash & Short-Term Investments $3.26M $5.65M $1.44M $3.04M $5.10M $6.99M $8.51M $9.72M
Total Current Assets $3.91M $6.17M $2.09M $3.94M $5.61M $7.53M $9.42M $10.82M
Property, Plant & Equipment, Net $896K $671K $748K $764K $763K $821K $843K $882K
Total Non-Current Assets $1.96M $1.81M $1.93M $2.03M $2.11M $2.15M $2.11M $2.21M
Total Assets $5.86M $7.98M $4.02M $5.97M $7.72M $9.68M $11.53M $13.03M
Accounts Payable $1.33M $1.27M $1.23M $1.24M $904K $931K $1.07M $924K
Other Current Liabilities $13K -- $13K $5.3K $17K -- $136K $179K
Total Current Liabilities $1.70M $1.62M $1.58M $1.57M $1.24M $1.22M $1.44M $1.33M
Total Non-Current Liabilities $1.97M $2.71M $908K $1.01M $1.11M $1.22M $1.20M $1.28M
Total Liabilities $3.67M $4.33M $2.49M $2.57M $2.34M $2.44M $2.64M $2.61M
Total Debt (incl. Leases) $1.00M $1.09M $1.16M $1.24M $1.32M $1.39M $1.33M $1.39M
Common Stock $9 $9 $8 $8 $8 $8 $8 $8
Retained Earnings -$28.59M -$26.35M -$23.47M -$21.10M -$18.45M -$16.16M -$13.80M -$11.95M
Total Stockholders' Equity $2.19M $3.65M $1.53M $3.40M $5.37M $7.24M $8.88M $10.42M
Total Equity $2.19M $3.65M $1.53M $3.40M $5.37M $7.24M $8.88M $10.42M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$9.16M -$5.86M -$2.04M
Depreciation & Amortization $235K $213K $145K
Stock-Based Compensation $1.99M $1.13M $282K
Change in Receivables $220K $145K -$73K
Operating Cash Flow -$6.50M -$8.51M -$1.18M
Capital Expenditure -$170K -$396K -$289K
Free Cash Flow -$6.67M -$8.90M -$1.47M
Investing Cash Flow -$150K -$359K -$311K
Common Stock Issued -- $14.53M --
Financing Cash Flow -$28K $18.52M $1.00M
Net Change in Cash -$6.68M $9.65M -$492K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.24M -$2.88M -$2.37M -$2.66M -$2.29M -$2.36M -$1.86M -$1.84M
Depreciation & Amortization $69K $65K $62K $61K $59K $59K $57K $54K
Stock-Based Compensation $776K $1.22M $501K $678K $426K $567K $317K $317K
Change in Receivables -$16K $102K $214K -$215K -$45K $338K $142K -$183K
Operating Cash Flow -$2.22M -$1.64M -$1.52M -$1.97M -$1.86M -$1.54M -$1.13M -$5.71M
Capital Expenditure -$310K $1 -$58K -$75K -$13K -$51K -$31K -$210K
Free Cash Flow -$2.53M -$1.64M -$1.58M -$2.05M -$1.87M -$1.59M -$1.16M -$5.92M
Investing Cash Flow -$165K $1 -$58K -$75K -$13K -$31K -$31K -$210K
Financing Cash Flow -$7.4K $5.85M -$13K -$11K -- -- -$43K $15.40M
Net Change in Cash -$2.39M $4.21M -$1.59M -$2.06M -$1.89M -$1.53M -$1.21M $9.49M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -- -- -2563.5%
Net Profit Margin -- -- -2909.1%
Return on Equity (ROE) -269.6% -56.2% --
Return on Assets (ROA) -153.4% -45.0% -57.3%
Current Ratio 2.51x 8.12x 0.50x
Quick Ratio 1.94x 7.29x 0.03x
Debt to Equity 0.37x 0.13x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -462.8% -278.9% -633.0% -269.6% -155.2% -106.5% -75.5% -56.2%
Return on Assets (ROA) -173.0% -127.7% -240.7% -153.4% -108.0% -79.7% -58.2% -45.0%
Current Ratio 2.30x 3.81x 1.32x 2.51x 4.53x 6.19x 6.52x 8.12x
Quick Ratio 1.92x 3.49x 0.91x 1.94x 4.12x 5.74x 5.89x 7.29x
Debt to Equity 0.46x 0.30x 0.76x 0.37x 0.25x 0.19x 0.15x 0.13x
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -503.1% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -979.7% --
Source: SEC EDGAR CompanyFacts (CIK 0002010788) · from March 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal